Central serous chorioretinopathy: a pathogenetic model
Open Access
- 1 February 2011
- journal article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 5, 239-43
Abstract
Peer reviewed article authored by (Antonio Caccavale, Filippo Romanazzi, Manuela Imparato, et al). Read article or submit your manuscript for publishing.Keywords
This publication has 58 references indexed in Scilit:
- Ketoconazole in the treatment of central serous chorioretinopathy: a pilot studyActa Ophthalmologica, 2010
- KETOCONAZOLE IN THE TREATMENT OF CHRONIC IDIOPATHIC CENTRAL SEROUS CHORIORETINOPATHYRetina, 2007
- MIFEPRISTONE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHYRetina, 2007
- Effect of dorzolamide and timolol on ocular blood flow in patients with primary open angle glaucoma and ocular hypertensionBritish Journal of Ophthalmology, 2005
- Acetylsalicylic acid inhibits the pituitary response to exercise-related stress in humansMedicine & Science in Sports & Exercise, 2001
- Theoretical investigation of the role of choriocapillaris blood flow in treatment of subfoveal choroidal neovascularization associated with age-related macular degenerationAmerican Journal of Ophthalmology, 2001
- Nadolol in the Treatment of Central Serous RetinopathyAmerican Journal of Ophthalmology, 1993
- Central Serous Chorioretinopathy in Endogenous HypercortisolismArchives of Ophthalmology (1950), 1993
- TYPE-A BEHAVIOR AND CENTRAL SEROUS CHORIORETINOPATHYRetina, 1987
- Indocyanine green angiography of central serous chorioretinopathyInternational Ophthalmology, 1986